News and Trends 30 Nov 2022TrialSpark acquires immunodermatology portfolio and creates Libertas Bio TrialSpark has announced the formation of Libertas Bio following the acquisition of a majority position in a portfolio of immunodermatology… November 30, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Oct 2022TrialSpark partners with Sanofi to acquire and develop clinical-stage novel therapies TrialSpark has announced a new partnership with global pharma company Sanofi to explore novel methods of bringing new treatments to… October 4, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email